Oura Integrates AI for Women's Health Insights
What happened
Health technology company Oura has rolled out a proprietary AI to provide personalized reproductive health insights for its users. The feature, which analyzes biometric data, reflects a broader trend of consumers, particularly women, adopting AI-driven tools for wellness and lifestyle management.
Why it matters
- The new feature is powered by Oura's first proprietary large language model, built by an in-house team of clinicians and experts specifically for women's health queries. It analyzes over 50 biometric signals, including temperature, sleep patterns, and heart rate variability, against a library of peer-reviewed research. - This AI integration is part of a rapidly growing FemTech market, which was valued at $39.29 billion in 2024 and is projected to reach $97.25 billion by 2030. The sector's growth is largely driven by advancements in AI and wearable technology. - The feature is currently being tested via Oura Labs, an opt-in experimental section of the app, allowing the company to gather user feedback before a general release. Oura emphasizes that the AI model runs on its own infrastructure, and user conversations will not be shared with third parties or used to train external AI systems. - This development builds on a series of women's health features from Oura, including its Period Prediction launched in 2022, Cycle Insights in 2023, and Fertile Window tracking in 2024. - Oura has previously partnered with the app Natural Cycles, which in 2018 became the first app to receive FDA approval for use as a digital contraceptive. This integration allowed Natural Cycles to use Oura's temperature data for its fertility algorithm. - The competitive landscape for wearables focused on women's health includes the Evie Ring, designed specifically for women, and the Samsung Galaxy Ring, which also offers AI-powered insights without a monthly subscription fee.
Key numbers
- It analyzes over 50 biometric signals, including temperature, sleep patterns, and heart rate variability, against a library of peer-reviewed research.
- This AI integration is part of a rapidly growing FemTech market, which was valued at $39.29 billion in 2024 and is projected to reach $97.25 billion by 2030.
- This development builds on a series of women's health features from Oura, including its Period Prediction launched in 2022, Cycle Insights in 2023, and Fertile Window tracking in 2024.
- Oura has previously partnered with the app Natural Cycles, which in 2018 became the first app to receive FDA approval for use as a digital contraceptive.
What happens next
- Oura emphasizes that the AI model runs on its own infrastructure, and user conversations will not be shared with third parties or used to train external AI systems.
Quick answers
What happened in Oura Integrates AI for Women's Health Insights?
Health technology company Oura has rolled out a proprietary AI to provide personalized reproductive health insights for its users. The feature, which analyzes biometric data, reflects a broader trend of consumers, particularly women, adopting AI-driven tools for wellness and lifestyle management.
Why does Oura Integrates AI for Women's Health Insights matter?
The new feature is powered by Oura's first proprietary large language model, built by an in-house team of clinicians and experts specifically for women's health queries. It analyzes over 50 biometric signals, including temperature, sleep patterns, and heart rate variability, against a library of peer-reviewed research. This AI integration is part of a rapidly growing FemTech market, which was valued at $39.29 billion in 2024 and is projected to reach $97.25 billion by 2030. The sector's growth is largely driven by advancements in AI and wearable technology. The feature is currently being tested via Oura Labs, an opt-in experimental section of the app, allowing the company to gather user feedback before a general release. Oura emphasizes that the AI model runs on its own infrastructure, and user conversations will not be shared with third parties or used to train external AI systems. This development builds on a series of women's health features from Oura, including its Period Prediction launched in 2022, Cycle Insights in 2023, and Fertile Window tracking in 2024. Oura has previously partnered with the app Natural Cycles, which in 2018 became the first app to receive FDA approval for use as a digital contraceptive. This integration allowed Natural Cycles to use Oura's temperature data for its fertility algorithm. The competitive landscape for wearables focused on women's health includes the Evie Ring, designed specifically for women, and the Samsung Galaxy Ring, which also offers AI-powered insights without a monthly subscription fee.
